1st European Symposium on Myeloid Regulatory Cells in Health and Disease

1–3 November 2018 • Essen (Germany)

Congress details


  • The deadline for the abstract submission is extended until August 30, 2018.

Welcome Note

Dear Friends and Colleagues,

It is my great pleasure to invite you to the 1st European Symposium on Myeloid Regulatory Cells (MRC) in Health and Disease.

In recent years we have all learned to appreciate the great plasticity and functional diversity of myeloid cells. In a disease setting, dendritic cells, monocytes, macrophages, neutrophils and myeloid-derived suppressor cells undergo abnormal differentiation and functional modulation. In this context disease promoting and immunosuppressive traits are acquired. On the other hand, regulation of overshooting immunity is also an important task of myeloid cells and this can be exploited therapeutically.

In order to bring together myeloid cell researchers, who until that time had been fragmented into either cell-type specific or disease specific communities, the network Mye-EUNITER (www.mye-euniter.eu) was formed in 2014.  Mye-EUNITER is supported by a COST grant provided by the European Union.

In conjunction with the final conference of the Mye-EUNITER network, we would like to invite you to participate in the 1st European Symposium on Myeloid Regulatory Cells in Essen, Germany. Mye-EUNITER members will share their most recent findings with you – the MRC research community. International experts have been invited to discuss the most recent developments in the field. Invited talks, oral abstract presentations, poster sessions and round table discussions are planned.

Conference topics focus on most recent findings about cell biology of MRC and address their role in disease: 

  • Autoimmunity and transplantation
  • Infectious disease
  • Cancer and inflammation
  • Cellular plasticity
  • Generation and regulation
  • Interaction with other cells
  • Microbiota and MRC biology

Please explore our conference website for more details.

In agreement with the Mye-EUNITER theme, it is our goal to provide a lively forum for molecular cell biologists and immunologists, but also translational and clinical scientists, all interested in understanding and harnessing the unique features of MRC.

On behalf of the Scientific Programme Committee I am looking forward to welcoming many of you to Essen, Germany in November.

With best wishes

Sven Brandau
(Conference Chair)